top of page
SERVICES
CUSTOM TMA
ROUTINE PATHOLOGY
IHC / IMMUNOFLUORESCENCE
ISH / FISH
CONTRACTED SERVICES
PRIMARY IHC ANTIBODIES
PATHOLOGY FIELD
Hermatopathology
DETECTION SYSTEMS
ANCILLARIES
CONTROL TMA
SKT961
Skin tumor tissue array, set 1, non-overlapping with SKT962, 96 cores, 48 cases from normal, premalignant and cancer tissues with progressive grades and stages in duplicates
Price per slide:
$289
Species:
Human
Cases:
48
Cores:
96
Core Size:
1.5mm
Core Thickness:
4um
Rows:
8
Columns:
12
Format:
Intended Usage:
For research use only. Designed for IHC or ISH based protein or RNA tissue profiling in evolution and progression of skin tumors.
8
X
12
For illustration purpose only. Actual product may vary.
Notes:
All the tissues were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or APES coated Superfrost slides. They can be stored for use at 4C for up to six months from the date of shipment. There may be 5 to 10% of tissue core loss.
Bake at 60C for ~60 minutes before use. If antigen retrieving is needed, it is important to avoid direct-boiling and high pH or high strength antigen retrieving buffer. For availability of complimentary IHC data, please contact us at info@pantomics.com.
ARRAY POSITION | IMAGE | SEX | AGE | ANATOMIC SITE | PATHOLOGY | NATURE | GRADE | STAGE (TNM) |
|---|---|---|---|---|---|---|---|---|
A01 |  | M | 53 | Skin, penis | Normal skin | Normal | ||
A02 |  | F | 15 | Skin, leg | Normal skin | Normal | ||
A03 |  | M | 57 | Skin, wrist | Chronic ulcer | Inflammatory | ||
A04 |  | M | 1 | Head and neck, ear | Skin polyp | Benign | ||
A05 |  | F | 20 | Skin, vulva | Condyloma acuminata (HPV+) | Benign | ||
A06 |  | M | 17 | Skin, penis | Condyloma acuminata acuminatum | Benign | ||
A07 |  | M | 25 | Skin | Granuloma | Inflammatory | ||
A08 |  | M | 10M | Skin | Hemangioma | Benign | ||
A09 |  | M | 22 | Subcutaneous tissue | Neurofibroma | Benign | ||
A10 |  | F | 44 | Subcutaneous tissue | Neurofibroma | Benign | ||
A11 |  | F | 24 | Scalp, subcutaneous tissue | Neurofibroma | Benign | ||
A12 |  | F | 67 | Subcutaneous tissue | Fibroma | Benign | ||
B01 |  | M | 53 | Skin, penis | Normal skin | Normal | ||
B02 |  | F | 15 | Skin, leg | Normal skin | Normal | ||
B03 |  | M | 57 | Skin, wrist | Chronic ulcer | Inflammatory | ||
B04 |  | M | 1 | Head and neck, ear | Skin polyp | Benign | ||
B05 |  | F | 20 | Skin, vulva | Condyloma acuminata (HPV+) | Benign | ||
B06 |  | M | 17 | Skin, penis | Condyloma acuminata acuminatum | Benign | ||
B07 |  | M | 25 | Skin | Granuloma | Inflammatory | ||
B08 |  | M | 10M | Skin | Hemangioma | Benign | ||
B09 |  | M | 22 | Subcutaneous tissue | Neurofibroma | Benign | ||
B10 |  | F | 44 | Subcutaneous tissue | Neurofibroma | Benign | ||
B11 |  | F | 24 | Scalp, subcutaneous tissue | Neurofibroma | Benign | ||
B12 |  | F | 67 | Subcutaneous tissue | Fibroma | Benign | ||
C01 |  | M | 50 | Skin, penis | Squamous cell carcinoma | Malignant | I | T1N0M0 |
C02 |  | M | 59 | Skin, face | Squamous cell carcinoma | Malignant | I | T1N0M0 |
C03 |  | M | 67 | Skin, penis | Squamous cell carcinoma | Malignant | I | T1N0M0 |
C04 |  | M | 40 | Skin, penis | Squamous cell carcinoma | Malignant | I | T1N0M0 |
C05 |  | F | 62 | Skin | Squamous cell carcinoma | Malignant | I | T1N0M0 |
C06 |  | F | 50 | Skin, leg | Squamous cell carcinoma | Malignant | I | T2N0M0 |
C07 |  | M | 34 | Skin, penis | Squamous cell carcinoma | Malignant | I | T1N0M0 |
C08 |  | M | 79 | Skin | Squamous cell carcinoma | Malignant | I | T2N0M0 |
C09 |  | F | 53 | Skin, head | Squamous cell carcinoma | Malignant | I | T1N0M0 |
C10 |  | M | 47 | Skin, penis | Squamous cell carcinoma | Malignant | I | T1N1M0 |
C11 |  | M | 40 | Skin, penis | Squamous cell carcinoma | Malignant | I | T1N0M0 |
C12 |  | M | 71 | Skin, penis | Squamous cell carcinoma | Malignant | I | T1N0M0 |
D01 |  | M | 50 | Skin, penis | Squamous cell carcinoma | Malignant | I | T1N0M0 |
D02 |  | M | 59 | Skin, face | Squamous cell carcinoma | Malignant | I | T1N0M0 |
D03 |  | M | 67 | Skin, penis | Squamous cell carcinoma | Malignant | I | T1N0M0 |
D04 |  | M | 40 | Skin, penis | Squamous cell carcinoma | Malignant | I | T1N0M0 |
D05 |  | F | 62 | Skin | Squamous cell carcinoma | Malignant | I | T1N0M0 |
D06 |  | F | 50 | Skin, leg | Squamous cell carcinoma | Malignant | I | T2N0M0 |
D07 |  | M | 34 | Skin, penis | Squamous cell carcinoma | Malignant | I | T1N0M0 |
D08 |  | M | 79 | Skin | Squamous cell carcinoma | Malignant | I | T2N0M0 |
D09 |  | F | 53 | Skin, head | Squamous cell carcinoma | Malignant | I | T1N0M0 |
D10 |  | M | 47 | Skin, penis | Squamous cell carcinoma | Malignant | I | T1N1M0 |
D11 |  | M | 40 | Skin, penis | Squamous cell carcinoma | Malignant | I | T1N0M0 |
D12 |  | M | 71 | Skin, penis | Squamous cell carcinoma | Malignant | I | T1N0M0 |
E01 |  | M | 57 | Skin, penis | Squamous cell carcinoma | Malignant | I | T1N0M0 |
E02 |  | M | 61 | Skin, head | Squamous cell carcinoma | Malignant | II | T1N0M0 |
E03 |  | M | 78 | Skin, face | Squamous cell carcinoma | Malignant | II | T1N0M0 |
E04 |  | M | 53 | Skin, trunk | Squamous cell carcinoma | Malignant | II | T1N0M0 |
E05 |  | M | 67 | Skin, trunk | Squamous cell carcinoma | Malignant | II | T2N0M0 |
E06 |  | F | 65 | Skin, vulva | Squamous cell carcinoma | Malignant | II | T1N0M0 |
E07 |  | M | 36 | Skin, head | Squamous cell carcinoma | Malignant | II | T1N0M0 |
E08 |  | M | 72 | Skin, head | Squamous cell carcinoma | Malignant | III | T2N0M0 |
E09 |  | M | 62 | Skin, leg | Basal cell carcinoma | Malignant | T1N0M0 | |
E10 |  | M | 89 | Skin, face | Basal cell carcinoma | Malignant | T1N0M0 | |
E11 |  | M | 80 | Skin, face | Basal cell carcinoma | Malignant | T1N0M0 | |
E12 |  | F | 35 | Scalp, subcutaneous tissue | Neuroendocrine carcinoma | Malignant | T2N0M0 | |
F01 |  | M | 57 | Skin, penis | Squamous cell carcinoma | Malignant | I | T1N0M0 |
F02 |  | M | 61 | Skin, head | Squamous cell carcinoma | Malignant | II | T1N0M0 |
F03 |  | M | 78 | Skin, face | Squamous cell carcinoma | Malignant | II | T1N0M0 |
F04 |  | M | 53 | Skin, trunk | Squamous cell carcinoma | Malignant | II | T1N0M0 |
F05 |  | M | 67 | Skin, trunk | Squamous cell carcinoma | Malignant | II | T2N0M0 |
F06 |  | F | 65 | Skin, vulva | Squamous cell carcinoma | Malignant | II | T1N0M0 |
F07 |  | M | 36 | Skin, head | Squamous cell carcinoma | Malignant | II | T1N0M0 |
F08 |  | M | 72 | Skin, head | Squamous cell carcinoma | Malignant | III | T2N0M0 |
F09 |  | M | 62 | Skin, leg | Basal cell carcinoma | Malignant | T1N0M0 | |
F10 |  | M | 89 | Skin, face | Basal cell carcinoma | Malignant | T1N0M0 | |
F11 |  | M | 80 | Skin, face | Basal cell carcinoma | Malignant | T1N0M0 | |
F12 |  | F | 35 | Scalp, subcutaneous tissue | Neuroendocrine carcinoma | Malignant | T2N0M0 | |
G01 |  | M | 62 | Lymph node, inguinal | Metastatic melanoma | Metastasis | ||
G02 |  | M | 64 | Skin, chest | Melanoma | Malignant | ||
G03 |  | M | 60 | Skin, foot | Melanoma | Malignant | ||
G04 |  | F | 64 | Scalp, subcutaneous tissue | Plasmacytoma | Malignant | ||
G05 |  | F | 53 | Face, subcutaneous tissue | Fibrosarcoma? | Malignant | ||
G06 |  | M | 44 | Chest wall, subcutaneous tissue | Dermatofibrosarcoma protuberans | Malignant | ||
G07 |  | M | 45 | Scalp, subcutaneous tissue | Dermatofibrosarcoma protuberans | Malignant | ||
G08 |  | F | 64 | Skin, leg, subcutaneous tissue | Malignant fibrous histiocytoma | Malignant | ||
G09 |  | F | 41 | Trunk, subcutaneous tissue | Dermatofibrosarcoma protuberans | Malignant | ||
G10 |  | F | 69 | Skin, neck, dermis, subcutaneous tissue | Metastatic squamous cell carcinoma of unknown site | Metastasis | ||
G11 |  | M | 56 | Skin, vulva, subcutaneous tissue | Metastatic adenocarcinoma | Metastasis | ||
G12 |  | F | 81 | Chest wall, dermis, subcutaneous tissue | Metastatic breast carcinoma | Metastasis | ||
H01 |  | M | 62 | Lymph node, inguinal | Metastatic melanoma | Metastasis | ||
H02 |  | M | 64 | Skin, chest | Melanoma | Malignant | ||
H03 |  | M | 60 | Skin, foot | Melanoma | Malignant | ||
H04 |  | F | 64 | Scalp, subcutaneous tissue | Plasmacytoma | Malignant | ||
H05 |  | F | 53 | Face, subcutaneous tissue | Fibrosarcoma? | Malignant | ||
H06 |  | M | 44 | Chest wall, subcutaneous tissue | Dermatofibrosarcoma protuberans | Malignant | ||
H07 |  | M | 45 | Scalp, subcutaneous tissue | Dermatofibrosarcoma protuberans | Malignant | ||
H08 |  | F | 64 | Skin, leg, subcutaneous tissue | Malignant fibrous histiocytoma | Malignant | ||
H09 |  | F | 41 | Trunk, subcutaneous tissue | Dermatofibrosarcoma protuberans | Malignant | ||
H10 |  | F | 69 | Skin, neck, dermis, subcutaneous tissue | Metastatic squamous cell carcinoma of unknown site | Metastasis | ||
H11 |  | M | 56 | Skin, vulva, subcutaneous tissue | Metastatic adenocarcinoma | Metastasis | ||
H12 |  | F | 81 | Chest wall, dermis, subcutaneous tissue | Metastatic breast carcinoma | Metastasis |
bottom of page